💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Gilead Sciences, Inc. (GILD)
« Back to company indexGILD Chatter Timeline
Stock Ticker for GILD
Most Active Tweeters for GILD
| User | Tweets |
|---|---|
| @HealthcareBeat | 12 |
| @MaisaCorp | 7 |
| @Escells | 7 |
| @Gambiste1 | 6 |
| @alexserri1 | 6 |
Recent Tweets for GILD
 |
@KaladinTD $GILD Daily https://t.co/a5EWyHTP7D October 18th 2020, 7:10pm |
 |
@pharmamaven $BSGM MMPD + $GILD Remdisivir combo reads out this QTR is Sick Grade 3 patients as Gov't publicly states its lookin… https://t.co/QCMn3CqgIy October 18th 2020, 7:10pm |
 |
@markemoran RT @pharmamaven: FDA's Woodcock (Operation Warp Speed therapeutic lead) is looking for oral anti-virals & combo's to enhance $GILD Remdesi… October 18th 2020, 6:10pm |
|
@pharmamaven FDA's Woodcock (Operation Warp Speed therapeutic lead) is looking for oral anti-virals & combo's to enhance $GILD… https://t.co/K5XbBtGIDt October 18th 2020, 6:10pm |
 |
@FintwitBoss RT @psk2329: $GILD monthly, yikes.. https://t.co/upoT5ibSWo October 18th 2020, 6:10pm |
 |
@psk2329 $GILD monthly, yikes.. https://t.co/upoT5ibSWo October 18th 2020, 6:10pm |
 |
@DawgeCapital RT @HealthcareBeat: Eli Lilly to continue other COVID-19 antibody drug trials after pausing one on safety concerns $GILD https://t.co/jaQzX… October 18th 2020, 12:10pm |
 |
@Stonefoxcapital $ABBV buy the weakness $GILD https://t.co/JKxIwo5hkY October 18th 2020, 11:10am |
 |
@HNtech2 Bad for $GILD for a decrease in cases in the longer term. May also affect less to antibody drugs like $REGN and… https://t.co/vUHz1HpBRt October 18th 2020, 10:10am |
 |
@ShockExchange RT @JohnCendpts: #3 Gilead feels the heat as close ally Galapagos reports a big setback on one of their top experimental drugs $GILD $GLPG… October 18th 2020, 10:10am |
 |
@JohnCendpts #3 Gilead feels the heat as close ally Galapagos reports a big setback on one of their top experimental drugs $GILD… https://t.co/QnJIbqKDhF October 18th 2020, 10:10am |
 |
@Gambiste1 RT @truthbe62241081: @WHO claims their "global" (aka CCP) study resulted in failed Remdesivir when in fact their own study SUPPORTS $GILD's… October 18th 2020, 9:10am |
|
@Gambiste1 RT @SeekingAlpha: $GILD - Gilead: 'Failed' Remdesivir Solidarity Study Might Really Show Efficacy. https://t.co/qLNS81hwsG #stockmarket #fi… October 18th 2020, 9:10am |
|
@Gambiste1 RT @FundaQuental: I am buying $GILD at these levels. expectations around COVID at low after WHO outcome. HIV franchise remains, HCV cash co… October 18th 2020, 9:10am |
 |
@NickytaLeb Read this story about $GILD and Remdesivir. Let's not make the same mistake with vaccines. Let's not have "the re… https://t.co/hxtnWeBv1t October 17th 2020, 8:10pm |
 |
@chrissoria25 $GILD https://t.co/RbXMcfC97e October 17th 2020, 7:10pm |
 |
@GG_Aguado @Marce79386451 @H_01101000 No se confundan con el laboratorio.... $GILD (US) = Gilead Sciences Inc $GILD (UK) = Guild Esports PLC October 17th 2020, 7:10pm |
 |
@slullyman #BTFDER Buying $GILD ($2) October 17th 2020, 7:10pm |
 |
@Gerberkawasakl RT @GerberKawasaki: This can’t be good. Mixing two experimental drugs... $gild $regn https://t.co/o2I58XSYiw October 17th 2020, 4:10pm |
 |
@CHItraders Remdesivir questioned by WHO trial; women take virus more seriously than men $GILD https://t.co/zKT7LvrBb6 October 17th 2020, 12:10pm |
 |
@YuZhu4 RT @sales_js: $GILD should buyout $HGEN now, next year could quadruple cause of carT and KRAS, potential leaders in covid19 with REGN and L… October 17th 2020, 12:10pm |
 |
@FlyrUsr $GILD #covid19 #Election2020 ? https://t.co/2mw6R9B1YJ October 17th 2020, 11:10am |
 |
@HealthcareBeat FACTBOX-Latest on the worldwide spread of coronavirus $PFE $GILD https://t.co/sRuROcxeUW October 17th 2020, 11:10am |
 |
@Queencynt RT @kylewdennis: Excellent trade there on $GILD Rodney! October 17th 2020, 10:10am |
 |
@sales_js WHO: Remdesivir Does Not Substantially Affect COVID-19 Patient Mortality @themotleyfool #stocks $GILD https://t.co/qBzA0k7pwQ October 17th 2020, 10:10am |
 |
@sleekoptions Peak profit for the last 6 expired option alerts for $GILD 22.14% | 64.75% | 21.82% | 105.48% | 10.26% | 44.30% |… https://t.co/nwadWKwg90 October 17th 2020, 9:10am |
|
@sleekoptions $GILD [Oct-16 63.50 Puts] Option volume Up +177.78% | Volume: 100 vs 36| October 17th 2020, 9:10am |
|
@sleekoptions $GILD - Monthly performance of the algo based option alerts posted for GILD https://t.co/6mDF1CkHRP October 17th 2020, 9:10am |
|
@sleekoptions $GILD - Last six months, 27 option alerts peaked above 100% after they were triggered by the algo… https://t.co/CQD8agFAJy October 17th 2020, 9:10am |
|
@sleekoptions $GILD - View historical options performance for GILD https://t.co/yxGR27fJ7z https://t.co/KjJzX7qCYN October 17th 2020, 9:10am |
 |
@bitex2047 The best defend of @WHO study is to stop purchasing #remdesivir . However, as $GILD ridiculed? “today WHO has prequ… https://t.co/NcbRR7qDKC October 17th 2020, 9:10am |
|
@HealthcareBeat ANALYSIS- Sales of first big COVID-19 drug, remdesivir, may disappoint $GILD https://t.co/fHm7O9zy7Y October 17th 2020, 8:10am |
 |
@bluetheabbyssi1 RT @mchilberg: I fully expect more $SGMO updates from $GILD collab in C21. The Covid slow down can be seen in the reduced R&D reimb and ev… October 17th 2020, 6:10am |
 |
@Tickeron $GILD in Downtrend: 50-day Moving Average moved below 200-day Moving Average on September 10, 2020. View odds for t… https://t.co/hQvP4gyVjs October 17th 2020, 6:10am |
|
@HealthcareBeat European advisory group backs Gilead's KTE-X19 in white blood cell cancer $GILD https://t.co/Tg9VbdJwt2 October 17th 2020, 5:10am |
 |
@mayaeart RT @BakkenShale: Could Gilead Sciences Have an HIV Cure Waiting in the Wings? https://t.co/aoZzIfSkxH $GILD October 17th 2020, 4:10am |
 |
@Alexey_Boogrow @Pharmdca What happened to the $gild stock? looking for the second bottom? October 17th 2020, 4:10am |
|
@HealthcareBeat UPDATE 2-Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug $GILD https://t.co/IG5dvZkqVD October 17th 2020, 3:10am |
|
@HealthcareBeat Remdesivir has ‘little or no effect’ in reducing coronavirus deaths, WHO says $GILD https://t.co/Stxz00fP8o October 17th 2020, 3:10am |
 |
@RBPOCMD RT @pharmamaven: $BSGM MMPD+Remdesivir Grade 3 where REM alone failed per NEJM! $GILD CEO O’Day “ looking forward to results of combinatio… October 17th 2020, 12:10am |
 |
@CodeGnuts RT @OfficialHemp: $GILD Biotechnology < Gileads Drug was used by Trump when he had #COVID19 - Thats Technology! #Python #rstats #java #j… October 16th 2020, 8:10pm |
 |
@ThingsToDoVegas $GILD Look at 1 year chart - PT $90 October 16th 2020, 7:10pm |
 |
@MaisaCorp $GILD FDA Says Remdesivir EUA Letter Of Authorization, Reissued Oct 16 FDA SAYS VEKLURY MAY BE EFFECTIVE,KNOWN &… https://t.co/m1a6uHYe5P October 16th 2020, 7:10pm |
|
@sales_js It’s crazy that the only one with FDA EUA $GILD Remdesivir is foundto be not effective and not saving lives 212,000… https://t.co/xZOEphJShZ October 16th 2020, 7:10pm |
 |
@fmlcapital Will this be the quarter $GILD breaks? If you’ve ever worked there you’re probably betting it will. https://t.co/jmNUTGNwzF October 16th 2020, 7:10pm |
|
@ThingsToDoVegas While the CEO had an interview with CNBC about #COVID19 Gilead Sciences $GILD company's CEO said "Remdesivir si… https://t.co/BrWpPadtQp October 16th 2020, 6:10pm |
 |
@Escells While the CEO had an interview with CNBC about #COVID19 Gilead Sciences $GILD company's CEO said "Remdesivir si… https://t.co/EOWXbDeVho October 16th 2020, 6:10pm |
|
@alexserri1 $GILD - WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients https://t.co/O7Ix9rKhPP October 16th 2020, 6:10pm |
 |
@QUIX_MASTERMIND Up 25% on $GILD short. I looked at the data, and despite the very positive press, I myself concluded that Remdesivi… https://t.co/dhkDz7n1iI October 16th 2020, 6:10pm |
|
@MaisaCorp $GILD concerned that the data from WHO open-label global trial have not undergone the rigorous review required to a… https://t.co/RXmHq7cYvS October 16th 2020, 6:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
